Abstract

Background. Problem of treatment of gastrointestinal bleeding remains relevant. According to the Center of Medical Statistics of the Ukraine Health Ministry - total mortality of gastrointestinal bleeding in Ukraine is 5, 87%. In 2017, 18968 patients were hospitalized, of which 35, 56% with late hospitalization (> 24 hours). Mortality of gastrointestinal bleeding in Ukraine is 5, 87%, in Kiev - 7, 42%. Postoperative mortality in Ukraine is 5,15%, late hospitalization (>24h) — 7,86%; in Kyiv - 3,33%, late hospitalization — 6,32%. Endoscopic hemostasis reduces both general and postoperative mortality 3-4 times. There are a number of methods for endoscopic hemostasis: chemical (Caproferr, Infuzol), injectable (Epinephrine 1:20, Terlipressin), monopolar coagulation, argonoplasmic coagulation, laser coagulation, and clapping. Objective. We have proposed endoscopic high-frequency welding bipolar coagulation with a probe (Patented No. 115147, Application number u201608620 dated 10.04.17), which is carried out through the instrumental channel of the endoscope to the bleeding site. Methods. Welding of the vessel is provided by the high-frequency bipolar apparatus EK-300 M1. In order to evaluate the effectiveness of our method we conducted an experiment on pigs with morphological verification of the vessel's condition. We used two different probes for high-frequency welding bipolar coagulation, connected to the EK-300 M1 for welding bleeding vessel. Results. After coagulation visually we could see that bleeding was stopped in all cases. Morphologically was found that for stopping bleeding of vessels up to 1mm in diameter the most effective is the use of a probe 1 with an exposure time of 15s, for vessels more than 1mm is effective to use a probe 2 with an exposure time of 30s. Conclusion. Taking into account the results of our study and disadvantages of already existing methods, high-frequency welding bipolar electrocoagulation has its own advantages (superficial effect on tissue, good coagulation effect with bleeding vessels 2-3mm and more, can be used in patients with artificial pacemaker), therefore it is new expedient and justified method of endoscopic stopping of bleeding.

Highlights

  • Oparin S.O., Dyadyk O.O., Feleshtinsky J.P., Sorokin B.V., Kozlova K.S., Lutsenko D.V., Gruzinskiy O.V

  • There are a number of methods for endoscopic hemostasis: chemical (Caproferr, Infuzol), injectable (Epinephrine 1:20, Terlipressin), monopolar coagulation, argonoplasmic coagulation, laser coagulation, and clapping

  • We have proposed endoscopic high-frequency welding bipolar coagulation with a probe (Patented No 115147, Application number u201608620 dated 10.04.17), which is carried out through the instrumental channel of the endoscope to the bleeding site

Read more

Summary

Introduction

Oparin S.O., Dyadyk O.O., Feleshtinsky J.P., Sorokin B.V., Kozlova K.S., Lutsenko D.V., Gruzinskiy O.V. Taking into account the results of our study and disadvantages of already existing methods, high-frequency welding bipolar electrocoagulation has its own advantages (superficial effect on tissue, good coagulation effect with bleeding vessels 2-3mm and more, can be used in patients with artificial pacemaker), it is new expedient and justified method of endoscopic stopping of bleeding. При морфологічному дослідженні біоптатів артерій другої підгрупи I групи виявлена субтотальна та тотальна облітерація просвіту судин з коагуляцією ендотелію, набряком стінки артерії.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.